-
Je něco špatně v tomto záznamu ?
Shared and Distinct Patterns of Oligodendroglial Response in α-Synucleinopathies and Tauopathies
Z. Rohan, I. Milenkovic, MI. Lutz, R. Matej, GG. Kovacs,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
PubMed
27678346
DOI
10.1093/jnen/nlw087
Knihovny.cz E-zdroje
- MeSH
- alfa-synuklein metabolismus MeSH
- lidé středního věku MeSH
- lidé MeSH
- mozek metabolismus patologie MeSH
- neurodegenerativní nemoci metabolismus patologie MeSH
- oligodendroglie metabolismus patologie MeSH
- proteiny nervové tkáně metabolismus MeSH
- proteiny tau metabolismus MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- tauopatie metabolismus patologie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Pathological protein deposits in oligodendroglia are common but variable features of various neurodegenerative conditions. To evaluate oligodendrocyte response in neurodegenerative diseases (NDDs) with different extents of oligodendroglial protein deposition we performed immunostaining for tubulin polymerization-promoting protein p25α (TPPP/p25α), α-synuclein (α-syn), phospho-tau, ubiquitin, myelin basic protein, and the microglial marker HLA-DR. We investigated cases of multiple system atrophy ([MSA] n = 10), Lewy body disease ([LBD] n = 10), globular glial tauopathy ([GGT] n = 7) and progressive supranuclear palsy ([PSP] n = 10). Loss of nuclear TPPP/p25α immunoreactivity correlated significantly with the degree of microglial reaction and loss of myelin basic prtein density as a marker of tract degeneration. This was more prominent in MSA and GGT, which, together with enlarged cytoplasmic TPPP/p25α immunoreactivity and inclusion burden allowed these disorders to be grouped as predominant oligodendroglial proteinopathies. However, distinct features, ie more colocalization of α-syn than tau with TPPP/p25α, more obvious loss of oligodendrocyte density in MSA, but more prominent association of tau protein inclusions in GGT to loss of nuclear TPPP/p25α immunoreactivity, were also recognized. In addition, we observed previously underappreciated oligodendroglial α-synuclein pathology in the pallidothalamic tract in LBD. Our study demonstrates common and distinct aspects of oligodendroglial involvement in the pathogenesis of diverse NDDs.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17023674
- 003
- CZ-PrNML
- 005
- 20170908094434.0
- 007
- ta
- 008
- 170720s2016 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/jnen/nlw087 $2 doi
- 035 __
- $a (PubMed)27678346
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Rohan, Zdenek $u From the Department of Pathology and Molecular Medicine, Thomayer Hospital, Prague, Czech Republic (ZR, RM), Institute of Neurology, Medical University of Vienna, Vienna, Austria (IM, MIL, GGK), and Institute of Pathology of the First Faculty of Medicine of Charles University in Prague and General Teaching Hospital, Prague, Czech Republic (RM).
- 245 10
- $a Shared and Distinct Patterns of Oligodendroglial Response in α-Synucleinopathies and Tauopathies / $c Z. Rohan, I. Milenkovic, MI. Lutz, R. Matej, GG. Kovacs,
- 520 9_
- $a Pathological protein deposits in oligodendroglia are common but variable features of various neurodegenerative conditions. To evaluate oligodendrocyte response in neurodegenerative diseases (NDDs) with different extents of oligodendroglial protein deposition we performed immunostaining for tubulin polymerization-promoting protein p25α (TPPP/p25α), α-synuclein (α-syn), phospho-tau, ubiquitin, myelin basic protein, and the microglial marker HLA-DR. We investigated cases of multiple system atrophy ([MSA] n = 10), Lewy body disease ([LBD] n = 10), globular glial tauopathy ([GGT] n = 7) and progressive supranuclear palsy ([PSP] n = 10). Loss of nuclear TPPP/p25α immunoreactivity correlated significantly with the degree of microglial reaction and loss of myelin basic prtein density as a marker of tract degeneration. This was more prominent in MSA and GGT, which, together with enlarged cytoplasmic TPPP/p25α immunoreactivity and inclusion burden allowed these disorders to be grouped as predominant oligodendroglial proteinopathies. However, distinct features, ie more colocalization of α-syn than tau with TPPP/p25α, more obvious loss of oligodendrocyte density in MSA, but more prominent association of tau protein inclusions in GGT to loss of nuclear TPPP/p25α immunoreactivity, were also recognized. In addition, we observed previously underappreciated oligodendroglial α-synuclein pathology in the pallidothalamic tract in LBD. Our study demonstrates common and distinct aspects of oligodendroglial involvement in the pathogenesis of diverse NDDs.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a mozek $x metabolismus $x patologie $7 D001921
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a proteiny nervové tkáně $x metabolismus $7 D009419
- 650 _2
- $a neurodegenerativní nemoci $x metabolismus $x patologie $7 D019636
- 650 _2
- $a oligodendroglie $x metabolismus $x patologie $7 D009836
- 650 _2
- $a tauopatie $x metabolismus $x patologie $7 D024801
- 650 _2
- $a alfa-synuklein $x metabolismus $7 D051844
- 650 _2
- $a proteiny tau $x metabolismus $7 D016875
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Milenkovic, Ivan $u From the Department of Pathology and Molecular Medicine, Thomayer Hospital, Prague, Czech Republic (ZR, RM), Institute of Neurology, Medical University of Vienna, Vienna, Austria (IM, MIL, GGK), and Institute of Pathology of the First Faculty of Medicine of Charles University in Prague and General Teaching Hospital, Prague, Czech Republic (RM).
- 700 1_
- $a Lutz, Mirjam I $u From the Department of Pathology and Molecular Medicine, Thomayer Hospital, Prague, Czech Republic (ZR, RM), Institute of Neurology, Medical University of Vienna, Vienna, Austria (IM, MIL, GGK), and Institute of Pathology of the First Faculty of Medicine of Charles University in Prague and General Teaching Hospital, Prague, Czech Republic (RM).
- 700 1_
- $a Matej, Radoslav $u From the Department of Pathology and Molecular Medicine, Thomayer Hospital, Prague, Czech Republic (ZR, RM), Institute of Neurology, Medical University of Vienna, Vienna, Austria (IM, MIL, GGK), and Institute of Pathology of the First Faculty of Medicine of Charles University in Prague and General Teaching Hospital, Prague, Czech Republic (RM).
- 700 1_
- $a Kovacs, Gabor G $u From the Department of Pathology and Molecular Medicine, Thomayer Hospital, Prague, Czech Republic (ZR, RM), Institute of Neurology, Medical University of Vienna, Vienna, Austria (IM, MIL, GGK), and Institute of Pathology of the First Faculty of Medicine of Charles University in Prague and General Teaching Hospital, Prague, Czech Republic (RM).
- 773 0_
- $w MED00010065 $t Journal of neuropathology and experimental neurology $x 1554-6578 $g Roč. 75, č. 12 (2016), s. 1100-1109
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27678346 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170720 $b ABA008
- 991 __
- $a 20170908095035 $b ABA008
- 999 __
- $a ok $b bmc $g 1239355 $s 984587
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 75 $c 12 $d 1100-1109 $i 1554-6578 $m Journal of neuropathology and experimental neurology $n J Neuropathol Exp Neurol $x MED00010065
- LZP __
- $a Pubmed-20170720